TELK

Telik and MabVax Therapeutics Announce Definitive Merger Agreement

[PR Newswire] – PALO ALTO, Calif., May 12, 2014 /PRNewswire/ — Telik, Inc. (TELK), a clinical stage oncology drug development company, and MabVax Therapeutics, Inc., a privately held cancer immunotherapy company, have entered into a definitive merger ag moreView todays social media effects on TELKView the latest stocks trending across Twitter. Click to view dashboardSee who Telik is hiring next, […]

MabVax Therapeutics And Telik Sign Definitive Merger Agreement

[PR Newswire] – SAN DIEGO, May 12, 2014 /PRNewswire/ — MabVax Therapeutics, Inc., a privately held cancer immunotherapy company and Telik, Inc. (TELK), aclinical stage oncology drug development company have entered into a definitive merger agreement. Up moreView todays social media effects on TELKView the latest stocks trending across Twitter. Click to view dashboardSee who Telik is hiring next, click […]

Telik Announces Fourth Quarter And 2012 Year End Financial Results And 2013 Financial Guidance

[PR Newswire] – PALO ALTO, Calif., March 15, 2013 /PRNewswire/ — Telik, Inc. (Nasdaq: TELK) reported a net loss of $1.8 million, or $0.66 per share, for the three months ended December 31, 2012, compared with a net loss … moreView todays social media effects on TELKView the latest stocks trending across Twitter. Click to view dashboardSee who Telik is […]